Diversity regarding presence/absence of TP53 mutations was identified in CTCs from colorectal cancer patients with mutation frequencies concordant with previous studies (38.7%; 12/31) but with some disparities with tissue showing wild type TP53 [16]. Here, TP53 is linked to colorectal cancer.